# Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

> **NCT07636148** · — · RECRUITING · sponsor: **Mark C Burgmans, MD PhD** · enrollment: 2000 (estimated)

## Conditions studied

- Liver Cancer (Primary and Metastatic)
- Lung Cancer (Diagnosis)
- Bone Cancer Metastatic
- Bone Cancer Tumor
- Kidney Tumors
- Renal Cancer
- Hepatocellular Carcinoma (HCC)
- Renal Cell Carcinoma (Kidney Cancer)
- Renal Cell Carcinoma (RCC)
- Musculoskeletal Cancers
- Musculoskeletal Tumors
- Bone Tumors
- Lung Tumors

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07636148
- **Lead sponsor:** Mark C Burgmans, MD PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636148, "Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07636148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*